• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者长期随访的ABO血型不相容成人活体肝移植

Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients.

作者信息

Matsuno Naoto, Nakamura Yuki, Mejit Abudushukur, Hama Koichiro, Iwamoto Hitoshi, Konno Osamu, Jojima Yoshimaro, Akashi Isao, Iwahori Tohru, Ashizawa Tatsuhito, Nagao Takeshi

机构信息

Department of Surgery, Hachioji Medical Center, Tokyo Medical University, Hachioji, Tokyo, Japan.

出版信息

Clin Transplant. 2007 Sep-Oct;21(5):638-42. doi: 10.1111/j.1399-0012.2007.00702.x.

DOI:10.1111/j.1399-0012.2007.00702.x
PMID:17845639
Abstract

ABO-incompatible liver transplantation is usually contraindicated. The presence in the recipient of preformed anti-A/B antibodies located on endothelial cells raises the risk of antibody-mediated humoral rejection of the graft. We describe four successful cases of steroid withdrawal in adult patients who had living-donor liver transplantation from ABO-incompatible donors. Antirejection therapy included multiple perioperative plasmapheresis, splenectomy, and a triple immunosuppressive regimen with tacrolimus, methylprednisolone (MPSL), and cyclophosphamide or mycophenolate mofetil (MMF). The maintenance dose of immunosuppression did not differ from that of ABO-identical cases. After transplantation, intrahepatic arterial infusion therapy with prostaglandin E1 (PG E1) was used. As a result, all four patients were able to achieve long-term graft survival without steroid use. They all have good liver function and are leading normal lifestyles. Our experience with these four patients suggests the feasibility of controlling humoral rejection and other complications in adult ABO-incompatible living donor liver transplantations with intrahepatic arterial infusion of PGE1, splenectomy, and plasmapheresis with a regular base of immunosuppression protocol to prevent antibody-mediated humoral rejection.

摘要

ABO血型不相容的肝移植通常是禁忌的。受者体内位于内皮细胞上的预先形成的抗A/B抗体增加了移植物抗体介导的体液排斥反应的风险。我们描述了4例成年患者成功停用类固醇的案例,这些患者接受了来自ABO血型不相容供体的活体肝移植。抗排斥治疗包括围手术期多次血浆置换、脾切除术以及使用他克莫司、甲泼尼龙(MPSL)和环磷酰胺或霉酚酸酯(MMF)的三联免疫抑制方案。免疫抑制的维持剂量与ABO血型相同的病例没有差异。移植后,采用前列腺素E1(PGE1)进行肝内动脉灌注治疗。结果,所有4例患者均能在不使用类固醇的情况下实现长期移植物存活。他们的肝功能均良好,过着正常的生活方式。我们对这4例患者的经验表明,通过肝内动脉灌注PGE1、脾切除术以及定期进行血浆置换并结合常规免疫抑制方案来预防抗体介导的体液排斥反应,在成人ABO血型不相容的活体肝移植中控制体液排斥反应和其他并发症是可行的。

相似文献

1
Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients.肝硬化患者长期随访的ABO血型不相容成人活体肝移植
Clin Transplant. 2007 Sep-Oct;21(5):638-42. doi: 10.1111/j.1399-0012.2007.00702.x.
2
Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.一名乙型肝炎病毒肝硬化患者接受 ABO 血型不相容活体供肝肝移植治疗超出米兰标准的肝细胞癌后的长期无复发生存:病例报告
Transplant Proc. 2012 Mar;44(2):565-9. doi: 10.1016/j.transproceed.2012.01.029.
3
ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.ABO血型不相容的成人活体肝移植治疗肝细胞癌
Transplant Proc. 2008 Oct;40(8):2497-500. doi: 10.1016/j.transproceed.2008.07.054.
4
Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.ABO血型不相容的活体供肝肝移植术前抗CD20单克隆抗体输注治疗联合脾切除术及血浆置换的经验与问题
Clin Transplant. 2007 Jan-Feb;21(1):24-31. doi: 10.1111/j.1399-0012.2006.00572.x.
5
The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.血浆置换疗法在ABO血型不相容的成人活体肝移植围手术期管理中的作用。
Transplant Proc. 2006 Dec;38(10):3629-32. doi: 10.1016/j.transproceed.2006.10.122.
6
Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.成人ABO血型不相容肝移植成功病例:肝动脉内灌注治疗的有益效果:病例报告
Transplant Proc. 2004 Oct;36(8):2269-73. doi: 10.1016/j.transproceed.2004.08.094.
7
Adult living-donor liver transplantation with ABO-incompatible grafts.成人ABO血型不相容供肝活体肝移植
Transplantation. 2008 Mar 15;85(5):681-6. doi: 10.1097/TP.0b013e3181665172.
8
New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.ABO血型不相容肝移植的新免疫抑制方案:利妥昔单抗的应用、肝动脉灌注及脾脏保留
Transplant Proc. 2005 May;37(4):1718-9. doi: 10.1016/j.transproceed.2005.03.148.
9
The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.血液成分单采治疗在ABO血型不相容活体供肝移植中的作用:京都大学的经验
Ther Apher Dial. 2006 Oct;10(5):441-8. doi: 10.1111/j.1744-9987.2006.00409.x.
10
Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.ABO血型不相容的活体供肝移植的治疗策略及治疗性血液成分单采疗法的作用
Ther Apher Dial. 2005 Aug;9(4):285-91. doi: 10.1111/j.1744-9987.2005.00304.x.

引用本文的文献

1
Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients: A meta-analysis.评估肝移植患者同期脾切除术的疗效和安全性:一项荟萃分析。
Medicine (Baltimore). 2018 Mar;97(10):e0087. doi: 10.1097/MD.0000000000010087.
2
Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis.ABO 血型不相容肝移植受者的结局:系统评价和荟萃分析。
PLoS One. 2011 Jan 25;6(1):e16521. doi: 10.1371/journal.pone.0016521.